The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules
Clinical trial NCT04950933 · UNKNOWN
Trial details
- NCT number
- NCT04950933
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-12-31
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.